Q1 2022 Excelsior Newsletter
Some Good News Due to Upcoming Generics by Robert Kordella, RPh, MBA, Chief Clinical Officer Not all of the news is bad in the world
Some Good News Due to Upcoming Generics by Robert Kordella, RPh, MBA, Chief Clinical Officer Not all of the news is bad in the world
Medication Adherence: Is it a Waste of Money? by Shavsha Davis, Assistant Vice President
Diabetes: What’s driving non-specialty trend? by Matt Jarvis, PharmD, Vice President, Pharmacy Practice Leader
Dispense As Written Prescription Instructions and Their Impact on Plan Sponsors and Participants by
Common Sense Management of Narcolepsy and Cataplexy by Bob Kordella, R.Ph., MBA, Chief Clinical
November 30, 2020:Where We Are Today And When Will New Vaccines Be Approved? by
COVID-19 Vaccine Update by Bob Kordella, R.Ph., MBA, Chief Clinical Officer As several COVID-19
The Rebate Bubble by Jonalan Smith, PharmD, FASCP, Senior Vice President Everyone knows the
The Impact Of Humira Citrate-Free by Bob Kordella, R.Ph., MBA Humira is typically in
HIV PrEP Therapies by Darian Hurst, Vice President In June 2019, the United States
© Copyright 2019 Excelsior Solutions • Privacy Policy • All Rights Reserved